References
Brown, K. R.: Eine aktuelle Übersicht über die weltweit vorliegenden klinischen Erfahrungen mit Imipenem/ Cilastatin. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1986, 5: 415–418.
Jones, R. N.: Review of the in vitro spectrum of activity of imipenem. American Journal of Medicine 1985, 78, Supplement 6A: 22–32.
Sanders, C., Sanders, W. E.: Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 1983, 5: 639–648.
Salata, R. A., Gebhart, R. L., Palmer, D. L., Wade, B. H., Scheld, W. M., Groschel, D. H. M., Wenzel, R. P., Mandell, G. L., Duma, R. J.: Pneumonia treated with imipenem/cilastatin. Journal of the American Medical Association 1985, 78, Supplement 6A: 96–102.
Pedersen, S. S., Pressler, T., Høiby, N., Bentzon, M. W., Koch, C.: Imipenem/cilastatin treatment of multi-resistantPseudomonas aeruginosa lung infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy 1985, 16: 629–635.
Curtis, N. A., Eisenstadt, R. L., Rudd, C., White, A. J.: Induciblc type Iβ-lactamases of gram-negative bacteria and resistance toβ-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 17: 51–61.
Yoshimura, F., Nikaido, H.: Diffusion ofβ-lactam antibiotics through the porin channels ofEscherichia coli K-12. Antimicrobial Agents and Chemotherapy 1985, 27: 84–92.
Thabaut, A., Philippon, A., Meyran, M.: Activité comparée des β-lactamines actives surPseudomonas aeruginosa en fonction des phénotypes de résistance. Presse Médicale 1984: 768–771.
Cullmann, W., Büscher, K. H., Operkuch, W., Dick, W.: Häufigkeit und Ursachen der Resistenz gramnegativer Keime gegenüber Imipenem. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1986, 5: 249–260.
Quinn, J. P., Dudek, E. J., Divincenzo, C. A., Lucks, D. A., Lerner, S. A.: Emergence of resistance to imipenem during therapy forPseudomonas aeruginosa infections. Journal of Infectious Diseases 1986, 154: 289–294.
Büscher, K. H., Cullmann, W., Dick, W., Opferkuch, W.: Imipenem resistance inPseudomonas aeruginosa is due to a diminished expression of an outer membrane protein. Antimicrobial Agents and Chemotherapy 1987, 31: 703–708.
Krech, T., Naumann, P.: Resistenzentwicklungen unter Imipenem-Therapie beiPseudomonas aeruginosa. Immunität und Infektion 1986, 14: 224–226.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Opferkuch, W., Cullmann, W. Lack of cross-resistance between imipenem and other beta-lactam antibiotics forPseudomonas aeruginosa . Eur. J. Clin. Microbiol. 6, 330–332 (1987). https://doi.org/10.1007/BF02017634
Issue Date:
DOI: https://doi.org/10.1007/BF02017634